Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study
- PMID: 33592531
- PMCID: PMC8010503
- DOI: 10.1016/j.thromres.2021.01.023
Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study
Keywords: COVID-19; D-dimer; Pulmonary embolism; Unfractionated heparin.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MV Huisman received grants from ZONMW, Bayer Health Care, Pfizer-BMS, Boehringer-Ingelheim, Leo Pharma, all outside the submitted work. J Eikenboom received research support from CSL Behring and he has been teacher on educational activities of Roche, all outside the submitted work. FA Klok reports research support from Bayer Health Care, Bristol-Myers Squibb, Boehringer-Ingelheim, MSD, Daiichi-Sankyo, Actelion, the Dutch thrombosis association, The Netherlands Organisation for Health Research and Development and the Dutch Heart foundation, all outside the submitted work. The authors declare that they have no competing interests.
Figures
References
-
- Levi M., De Jonge E., Van Der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann. Med. 2004;36(1):41–49. - PubMed
-
- Qanadli S.D., El Hajjam M., Vieillard-Baron A., Joseph T., Mesurolle B., Oliva V.L., et al. New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am. J. Roentgenol. 2001;176(6):1415–1420. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
